State Food And Drug Administration
-
{
- All
- News
-
Zydus Lifesciences' Dasatinib Tablets Get USFDA Approval, To Manufacture At Ahmedabad Unit
The pharma major and its subsidiaries and affiliates received approval to manufacture the tablets in strengths 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.
-
Biocon Biologics’ Bengaluru Facilities Get VAI Tag From US Drug Regulator
The USFDA checks were carried out between July 15 and July 26 across six separate manufacturing units, Biocon Biologics said.
-
FDA Made 9 Observations Post Halol Unit Inspection: Sun Pharma
The United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Pharma said in a BSE filing.
-
Zydus Cadila Gets USFDA Nod For Anti-Infections Tablets
Zydus Cadila has received final approval from the US health regulator to market its Metronidazole tablets used for the treatment of infections caused by bacteria or parasites.
-
Lupin Launches Bacterial Infection Treatment Drug in US Market
Drug firm Lupin Ltd has launched its generic Ciprofloxacin, used for treating bacterial infections, in the American market and is expecting 180 days of market exclusivity.
-
Elon Musk Claims His Neuralink Brain Chip Could ‘Cure’ Tinnitus in 5 Years. but Don’t Hold Your Breath
Neuralink, a Silicon Valley start-up backed by Elon Musk, has developed a neuroprosthetic brain-computer interface device. According to Musk's claims, this chip might prove useful in curing tinnitus, the neurological condition that causes ringing in your ears, within next five years. Neuroscientists back Musk's claims as they are broadly optimis...
-
Pharma Slide: Valuations Versus Growth Risks
Bearish views continue to weigh on pharma, but is all lost? Niraj Shah examines the pros and cons.
-
Lupin Gains On U.S. Drug Regulator’s Approval For Generic Antidepressant
The tablets had total sales of $127.7 million till September 2016 in the U.S.
-
FDA Made 9 Observations Post Halol Unit Inspection: Sun Pharma
The United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Pharma said in a BSE filing.
-
Zydus Cadila Gets USFDA Nod For Anti-Infections Tablets
Zydus Cadila has received final approval from the US health regulator to market its Metronidazole tablets used for the treatment of infections caused by bacteria or parasites.
-
Ajanta Pharma Launches Blood Pressure Lowering Tablets In US
The product has been launched in four strengths 5mg20mg, 5mg40mg, 10mg20mg and 10mg40mg, Ajanta Pharma said.
-
Dr Reddy’s Joins Hands With Gland Pharma To Market 8 ANDAs In U.S.
The deal provides a boost to Dr Reddy’s injectable business in the U.S.
-
Sun Pharma, Lupin Recall Over 41,500 Drug Bottles In U.S.
The three drugs are used for high blood pressure, depression and anxiety in the U.S.
-
Cipla Gets USFDA Nod For Overactive Bladder Treating Drug
Pharma major Cipla on Friday said it has received final approval for its Abbreviated New Drug Application (ANDA) for Darifenacin extended-release tablets from the United States Food and Drug Administration (USFDA).
-
Zydus Recalls Over 2 Lakh Bottles of Anti-Depressant Drug in U.S.
A class II recall has been initiated, which is enforced when a violative product may cause adverse health effects on exposure or consumption.
-
Zydus Lifesciences' Dasatinib Tablets Get USFDA Approval, To Manufacture At Ahmedabad Unit
The pharma major and its subsidiaries and affiliates received approval to manufacture the tablets in strengths 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.
-
Biocon Biologics’ Bengaluru Facilities Get VAI Tag From US Drug Regulator
The USFDA checks were carried out between July 15 and July 26 across six separate manufacturing units, Biocon Biologics said.
-
FDA Made 9 Observations Post Halol Unit Inspection: Sun Pharma
The United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Pharma said in a BSE filing.
-
Zydus Cadila Gets USFDA Nod For Anti-Infections Tablets
Zydus Cadila has received final approval from the US health regulator to market its Metronidazole tablets used for the treatment of infections caused by bacteria or parasites.
-
Lupin Launches Bacterial Infection Treatment Drug in US Market
Drug firm Lupin Ltd has launched its generic Ciprofloxacin, used for treating bacterial infections, in the American market and is expecting 180 days of market exclusivity.
-
Elon Musk Claims His Neuralink Brain Chip Could ‘Cure’ Tinnitus in 5 Years. but Don’t Hold Your Breath
Neuralink, a Silicon Valley start-up backed by Elon Musk, has developed a neuroprosthetic brain-computer interface device. According to Musk's claims, this chip might prove useful in curing tinnitus, the neurological condition that causes ringing in your ears, within next five years. Neuroscientists back Musk's claims as they are broadly optimis...
-
Pharma Slide: Valuations Versus Growth Risks
Bearish views continue to weigh on pharma, but is all lost? Niraj Shah examines the pros and cons.
-
Lupin Gains On U.S. Drug Regulator’s Approval For Generic Antidepressant
The tablets had total sales of $127.7 million till September 2016 in the U.S.
-
FDA Made 9 Observations Post Halol Unit Inspection: Sun Pharma
The United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Pharma said in a BSE filing.
-
Zydus Cadila Gets USFDA Nod For Anti-Infections Tablets
Zydus Cadila has received final approval from the US health regulator to market its Metronidazole tablets used for the treatment of infections caused by bacteria or parasites.
-
Ajanta Pharma Launches Blood Pressure Lowering Tablets In US
The product has been launched in four strengths 5mg20mg, 5mg40mg, 10mg20mg and 10mg40mg, Ajanta Pharma said.
-
Dr Reddy’s Joins Hands With Gland Pharma To Market 8 ANDAs In U.S.
The deal provides a boost to Dr Reddy’s injectable business in the U.S.
-
Sun Pharma, Lupin Recall Over 41,500 Drug Bottles In U.S.
The three drugs are used for high blood pressure, depression and anxiety in the U.S.
-
Cipla Gets USFDA Nod For Overactive Bladder Treating Drug
Pharma major Cipla on Friday said it has received final approval for its Abbreviated New Drug Application (ANDA) for Darifenacin extended-release tablets from the United States Food and Drug Administration (USFDA).
-
Zydus Recalls Over 2 Lakh Bottles of Anti-Depressant Drug in U.S.
A class II recall has been initiated, which is enforced when a violative product may cause adverse health effects on exposure or consumption.
